AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 61 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,342,000 | +8.7% | 240,000 | -8.9% | 0.42% | +59.2% |
Q4 2021 | $1,235,000 | -56.1% | 263,400 | -42.2% | 0.26% | -50.2% |
Q3 2021 | $2,816,000 | -34.0% | 455,600 | -29.6% | 0.53% | -25.7% |
Q2 2021 | $4,264,000 | -30.2% | 647,000 | -22.5% | 0.71% | -21.2% |
Q1 2021 | $6,112,000 | +1702.9% | 835,000 | +1320.1% | 0.90% | +1940.9% |
Q4 2020 | $339,000 | – | 58,800 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AIGH Capital Management LLC | 1,986,176 | $12,275,000 | 2.58% |
Worth Venture Partners, LLC | 454,364 | $2,808,000 | 1.26% |
Opaleye Management Inc. | 455,600 | $2,816,000 | 0.53% |
J. Goldman & Co LP | 1,663,229 | $10,279,000 | 0.52% |
X-Square Capital, LLC | 92,283 | $570,000 | 0.30% |
NEA Management Company, LLC | 3,952,958 | $24,429,000 | 0.29% |
Birchview Capital, LP | 40,000 | $247,000 | 0.17% |
PERSONAL CFO SOLUTIONS, LLC | 23,000 | $142,000 | 0.03% |
PURA VIDA INVESTMENTS, LLC | 147,574 | $912,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 35,232 | $218,000 | 0.02% |